Wang, W.; Green, D.; Ibrahim, R.; Abdelnabi, M.; Pham, H.N.; Forst, B.; Allam, M.; Sarkis, P.; Bcharah, G.; Farina, J.;
et al. Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure. Biomedicines 2025, 13, 1108.
https://doi.org/10.3390/biomedicines13051108
AMA Style
Wang W, Green D, Ibrahim R, Abdelnabi M, Pham HN, Forst B, Allam M, Sarkis P, Bcharah G, Farina J,
et al. Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure. Biomedicines. 2025; 13(5):1108.
https://doi.org/10.3390/biomedicines13051108
Chicago/Turabian Style
Wang, Winston, Danielle Green, Ramzi Ibrahim, Mahmoud Abdelnabi, Hoang Nhat Pham, Beani Forst, Mohamed Allam, Patrick Sarkis, George Bcharah, Juan Farina,
and et al. 2025. "Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure" Biomedicines 13, no. 5: 1108.
https://doi.org/10.3390/biomedicines13051108
APA Style
Wang, W., Green, D., Ibrahim, R., Abdelnabi, M., Pham, H. N., Forst, B., Allam, M., Sarkis, P., Bcharah, G., Farina, J., Ayoub, C., Sorajja, D., & Arsanjani, R.
(2025). Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure. Biomedicines, 13(5), 1108.
https://doi.org/10.3390/biomedicines13051108
